Review



hematopoietic kit medium b  (STEMCELL Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STEMCELL Technologies Inc hematopoietic kit medium b
    Hematopoietic Kit Medium B, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hematopoietic+kit+medium+b/hematopoietic+kit+medium+b/ppr0820478-219-29-33
    Average 90 stars, based on 1 article reviews
    hematopoietic kit medium b - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Marker:

    Article Title: PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease
    Article Snippet: 470 Hematopoietic and iMicroglia Differentiation - iPSC Lines 1 and 3 471 Human iPSCs (Thermo Fisher Scientific, A18945-referred to herein as iPSC line 1, and 472 ATCC, ACS-1026- referred to herein as iPSC line 3), were maintained in mTESR-Plus 473 (STEMCELL Technologies, 100-0276) until seeding for differentiation. .. At ~80% 474 confluence hematopoietic differentiation was started as previously published39 On Day 4 475 cells were sorted for marker CD235a and replated on matrigel coated plates into 476 Hematopoietic Kit Medium B (STEMCELL Technologies, 05310) containing 10μM ROCK 477 inhibitor (ATCC, Y27632) at 500,000 cells per well of a 6-well plate. .. From this point 478 onward all steps from STEMCELL Technologies protocol were followed to generate highly 479 pure HPCs.

    Article Title: PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease
    Article Snippet: 470 Hematopoietic and iMicroglia Differentiation - iPSC Lines 1 and 3 471 Human iPSCs (Thermo Fisher Scientific, A18945-referred to herein as iPSC line 1, and 472 ATCC, ACS-1026- referred to herein as iPSC line 3), were maintained in mTESR-Plus 473 (STEMCELL Technologies, 100-0276) until seeding for differentiation. .. At ~80% 474 confluence hematopoietic differentiation was started as previously published39 On Day 4 475 cells were sorted for marker CD235a and replated on matrigel coated plates into 476 Hematopoietic Kit Medium B (STEMCELL Technologies, 05310) containing 10μM ROCK 477 inhibitor (ATCC, Y27632) at 500,000 cells per well of a 6-well plate. .. From this point 478 onward all steps from STEMCELL Technologies protocol were followed to generate highly 479 pure HPCs.



    Similar Products

    hematopoietic kit medium b  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc hematopoietic kit medium b
    Hematopoietic Kit Medium B, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hematopoietic+kit+medium+b/hematopoietic+kit+medium+b/ppr0820478-219-29-33
    Average 90 stars, based on 1 article reviews
    hematopoietic kit medium b - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results